Search results

From Self-sufficiency
Jump to: navigation, search
  • ...ournal|author=Harrison NL, Simmonds MA |title=Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex |journal=British J ...August | pmid = 19391150 | doi = 10.1002/syn.20647}}</ref> as well as a [[dopamine reuptake inhibitor]].{{Citation needed|date=April 2010}}
    69 KB (9,697 words) - 21:01, 24 September 2010
  • ...eptors without blocking the secretion of histamine. It also is a very weak dopamine antagonist.<ref>David J. McCann and Brett Roth, [http://www.emedicine.com/E [[Category:H1 receptor antagonists]]
    10 KB (1,347 words) - 21:10, 12 September 2010
  • |ImageFile2=Dopamine-3d-CPK.png ...cyclopedia.com/doc/1O87-ventraltegmentalarea.html Reference for VTA.</ref> Dopamine is also a [[neurohormone]] released by the [[hypothalamus]]. Its main funct
    48 KB (6,470 words) - 16:48, 27 September 2010
  • ...58:723–7. PMID 14186927.</ref> It appears to bind to [[dopamine receptor|dopamine D<sub>2</sub> receptors]] where it is a [[receptor antagonist]], and is als ...been superseded by the more effective [[5-HT3 antagonist|5-HT<sub>3</sub> antagonists]] (e.g. [[ondansetron]]).
    11 KB (1,453 words) - 16:49, 27 September 2010
  • ...</ref> Indeed, in humans given 30% N<sub>2</sub>O, benzodiazepine receptor antagonists reduced the subjective reports of feeling "high", but did not alter psycho- ...O.<ref name="branda"/> Several experiments have shown that opioid receptor antagonists applied directly to the brain block the antinociceptive effects of N<sub>2<
    61 KB (8,728 words) - 16:50, 27 September 2010
  • *[[N-arachidonoyl-dopamine]] (NADA) ...known [[monoamine]] [[neurotransmitter]]s, such as [[acetylcholine]] and [[dopamine]], endocannabinoids differ in numerous ways from them. For instance, they u
    49 KB (6,487 words) - 22:06, 21 September 2010
  • ...tor]] antagonist [[rimonabant]] (SR141716A) as well as [[opioid receptor]] antagonists (opioid blockers) [[naloxone]] and [[naloxonazine]].<ref name="Lupica 2004"
    50 KB (6,686 words) - 22:09, 21 September 2010
  • ...] for the [[Mu opioid receptor|μ receptor]] such that [[opioid receptor]] antagonists (e.g. [[naloxone]]) only partially reverse its effects. These two [[chemica ...own to act as an epsilon-opioid antagonist. Several selective agonists and antagonists are now available for the putative epsilon receptor,<ref name="pmid15246090
    59 KB (8,561 words) - 22:13, 21 September 2010
  • ...simplications for models of schizophrenia](2002)</ref> Other NMDA receptor antagonists include [[ketamine]], [[tiletamine]], and [[dextromethorphan]]. Although th ...= August | pmid = 19391150 | doi = 10.1002/syn.20647}}</ref> as well as [[dopamine reuptake inhibitor]]s.{{Citation needed|date=April 2010}}
    21 KB (3,002 words) - 21:02, 24 September 2010
  • ...lvinorin A in mice are blocked by κ-Opioid receptor [[receptor antagonist|antagonists]].<ref name="Zhang2005pabs">[[#refZhang2005|Zhang et al. 2005]], p.&nbsp;ab | title = Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide,
    133 KB (18,241 words) - 22:14, 21 September 2010
  • ...agonists--S(+)-ketamine, dextrorphan, and dextromethorphan--act as calcium antagonists on bovine cerebral arteries | journal = Journal of Neurosurgical Anesthesio ...ournal |author=Hargreaves R, Hill R, Iversen L |title=Neuroprotective NMDA antagonists: the controversy over their potential for adverse effects on cortical neuro
    26 KB (3,444 words) - 22:15, 21 September 2010
  • ...7.016 |url=}}</ref> GHB's sedative effects are blocked by GABA<sub>B</sub> antagonists. ...oxone]] and [[naltrexone]]. Dynorphin may play a role in the inhibition of dopamine release via [[kappa opioid receptor]]s.<ref>{{cite journal |author=Mamelak
    55 KB (7,839 words) - 21:04, 24 September 2010